Clinical Trial Update: A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating a monovalent pneumococcal conjugate vaccine candidate in healthy toddlers; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Monovalent pneumococcal conjugate vaccine candidate

Snippet

Sponsor: Pfizer | Conditions: Healthy Participants | Phase 2 | Status: COMPLETED | Results posted: 2025-05-08